Published in J Mol Biol on July 17, 2010
Phospholamban binds with differential affinity to calcium pump conformers. J Biol Chem (2011) 1.10
Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy. J Biol Chem (2012) 0.96
Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase. J Biol Chem (2011) 0.96
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized. J Biol Chem (2012) 0.93
Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase. Biophys J (2013) 0.91
Oligomeric interactions of sarcolipin and the Ca-ATPase. J Biol Chem (2011) 0.90
Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells. PLoS One (2011) 0.90
2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding. PLoS One (2012) 0.89
ATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening. Mol Pharmacol (2015) 0.80
Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex. J Biol Chem (2014) 0.79
Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban. J Biol Chem (2015) 0.77
Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer. Biophys J (2016) 0.75
Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol (2003) 5.05
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
Photobleaching-corrected FRET efficiency imaging of live cells. Biophys J (2004) 3.41
Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc Natl Acad Sci U S A (2003) 2.05
Optimization of pairings and detection conditions for measurement of FRET between cyan and yellow fluorescent proteins. Microsc Microanal (2006) 1.78
Sarcolipin and phospholamban mRNA and protein expression in cardiac and skeletal muscle of different species. Biochem J (2005) 1.60
Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study. Biochemistry (1999) 1.50
Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells. J Biol Chem (2008) 1.29
Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem (2009) 1.23
Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem (2000) 1.23
Förster transfer recovery reveals that phospholamban exchanges slowly from pentamers but rapidly from the SERCA regulatory complex. Circ Res (2007) 1.17
Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex. J Biol Chem (2008) 1.17
Localization of phospholamban in slow but not fast canine skeletal muscle fibers. An immunocytochemical and biochemical study. J Biol Chem (1986) 1.09
Spatial and dynamic interactions between phospholamban and the canine cardiac Ca2+ pump revealed with use of heterobifunctional cross-linking agents. J Biol Chem (2003) 1.09
Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure. J Biol Chem (1999) 0.98
Sarcoplasmic reticulum Ca(2+) atpase (SERCA) 1a structurally substitutes for SERCA2a in the cardiac sarcoplasmic reticulum and increases cardiac Ca(2+) handling capacity. Circ Res (2001) 0.93
Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. Biochemistry (2002) 0.92
SERCA1 expression enhances the metabolic efficiency of improved contractility in post-ischemic heart. J Mol Cell Cardiol (2009) 0.86
Targeting sarcoplasmic reticulum Ca2+ uptake to improve heart failure: hit or miss. Circ Res (2010) 0.85
Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest. Histochem Cell Biol (2009) 0.85
The beta2-agonist salbutamol affects the expression of phospholamban and both isoforms of SERCA in canine skeletal muscle and blocks changes in these induced by neuromuscular stimulation. Pflugers Arch (1998) 0.79
Fast- and slow-twitch isoforms (SERCA1 and SERCA2a) of sarcoplasmic reticulum Ca-ATPase are expressed simultaneously in chronically stimulated muscle fibers. Pflugers Arch (1997) 0.78
Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization. Physiol Genomics (2004) 2.37
Phospholamban oligomerization, quaternary structure, and sarco(endo)plasmic reticulum calcium ATPase binding measured by fluorescence resonance energy transfer in living cells. J Biol Chem (2008) 1.29
The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction. Mol Biol Cell (2008) 1.25
Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem (2009) 1.23
Phosphomimetic mutations increase phospholamban oligomerization and alter the structure of its regulatory complex. J Biol Chem (2008) 1.17
Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A. Proc Natl Acad Sci U S A (2011) 1.12
Phospholamban binds with differential affinity to calcium pump conformers. J Biol Chem (2011) 1.10
p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J Virol (2010) 1.08
Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin. J Biol Chem (2011) 1.02
Discovery of enzyme modulators via high-throughput time-resolved FRET in living cells. J Biomol Screen (2014) 0.97
TRIM5α associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology (2011) 0.97
The anti-apoptotic protein HAX-1 is a regulator of cardiac function. Proc Natl Acad Sci U S A (2009) 0.96
Localization of functional endothelin receptor signaling complexes in cardiac transverse tubules. J Biol Chem (2003) 0.96
Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase. J Biol Chem (2011) 0.96
Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase. Biophys J (2013) 0.91
Oligomeric interactions of sarcolipin and the Ca-ATPase. J Biol Chem (2011) 0.90
Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells. PLoS One (2011) 0.90
2-Color calcium pump reveals closure of the cytoplasmic headpiece with calcium binding. PLoS One (2012) 0.89
FRNK inhibition of focal adhesion kinase-dependent signaling and migration in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2010) 0.84
Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy. Cardiovasc Res (2011) 0.82
A structural mechanism for calcium transporter headpiece closure. J Phys Chem B (2015) 0.81
Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhesion targeting, tyrosine 168 phosphorylation, and competition for p130(Cas) binding. Arterioscler Thromb Vasc Biol (2011) 0.80